Vocal Biomarkers Market, by Therapeutic Application (Psychological Disorders, Respiratory Disorders, and Cardiovascular Disorders), by End User (Hospitals, Health Insurers, Academic & Research Institutions, and Government Organizations), and by Region (No
Description
Vocal Biomarkers Market, by Therapeutic Application (Psychological Disorders, Respiratory Disorders, and Cardiovascular Disorders), by End User (Hospitals, Health Insurers, Academic & Research Institutions, and Government Organizations), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson’s disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.
Market Dynamics
The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.
Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.
Key features of the study:
This report provides in-depth analysis of the global vocal biomarkers market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Coporation, and Cogito Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market
Detailed Segmentation:
Global Vocal Biomarkers Market, By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
Global Vocal Biomarkers Market, By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
Global Vocal Biomarkers Market, By Region:
North America
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
U.S.
Canada
Latin America
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Beyond Verbal, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Sonde Health
Sharecare, Inc.
IBM Coporation
Cogito Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson’s disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.
Market Dynamics
The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.
Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.
Key features of the study:
This report provides in-depth analysis of the global vocal biomarkers market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Coporation, and Cogito Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market
Detailed Segmentation:
Global Vocal Biomarkers Market, By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
Global Vocal Biomarkers Market, By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
Global Vocal Biomarkers Market, By Region:
North America
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
U.S.
Canada
Latin America
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapeutic Application:
Psychological Disorders
Depression and Anxiety
Parkinson’s Disease
Cognitive Impairment
Other Mental Illnesses
Respiratory Disorders
Cardiovascular Disorders
By End User:
Hospitals
Health Insurers
Academic & Research Institutions
Government Organizations
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Beyond Verbal, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Sonde Health
Sharecare, Inc.
IBM Coporation
Cogito Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
166 Pages
- 1. Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Therapeutic Application
- Market Snippet By End User
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Epidemiology/Prevalence/Incidence
- Mergers and Acquisitions
- New Product Approvals/Launch
- 4. Global Vocal Biomarkers Market, By Therapeutic Application, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Psychological Disorders
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Depression and Anxiety
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Parkinson’s Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Cognitive Impairment
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Other Mental Illnesses
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- 5. Global Vocal Biomarkers Market, By End User, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Health Insurers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Academic & Research Institutions
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- Government Organizations
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Vocal Biomarkers Market, By Regions, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Regions, 2017 - 2028
- North America
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2017 - 2028
- North America Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- North America Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Europe
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2017 - 2028
- Europe Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Europe Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Asia Pacific
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2017 - 2028
- Asia Pacific Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Asia Pacific Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Latin America
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2017 - 2028
- Latin America Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Latin America Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- Middle East & Africa (MEA)
- Market Share Analysis, By Segments, 2017 and 2028 (%)
- Y-O-Y Growth Analysis, By Segments, 2017 - 2028
- MEA Vocal Biomarkers Market, By Therapeutic Application
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- MEA Vocal Biomarkers Market, By End User
- Market Size and Forecast, 2017 - 2028 (US$ Million)
- 7. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Beyond Verbal, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Sonde Health
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Sharecare, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- IBM Coporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Cogito Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- 8. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 70 market data tables and 25 figures on "Vocal Biomarkers Market - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.